Showing results (171-180 of 191) with videos related to

Sort By:
Pageof 20
Journal of Medicinal Chemistry|December 26, 2015
Discovery of a Novel Inhibitor of Histone Lysine-Specific Demethylase 1A (KDM1A/LSD1) as Orally Active Antitumor AgentPaola Vianello, Oronza A Botrugno, Anna Cappa, et al.
Journal of Medicinal Chemistry|March 5, 2025
Design of Benzyl-triazolopyrimidine-Based NADPH Oxidase Inhibitors Leads to the Discovery of a Potent Dual Covalent NOX2/MAOB InhibitorBeatrice Noce, Sara Marchese, Marta Massari, et al.
ACS Chemical Biology|June 1, 2013
Protein recognition by short peptide reversible inhibitors of the chromatin-modifying LSD1/CoREST lysine demethylaseMarcello Tortorici, Maria Teresa Borrello, Maria Tardugno, et al.
ACS Infectious Diseases|May 6, 2017
A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase InhibitorsMarta Esposito, Sára Szadocka, Giulia Degiacomi, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
The glycine-arginine-rich motif of 53BP1 modulates RNA interactions necessary for its liquid-liquid phase separation during DNA Damage ResponseFederica Terraneo, Marta Ceccon, Oscar Sapkota, et al.
Journal of Medicinal Chemistry|December 12, 2013
Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activitiesDante Rotili, Stefano Tomassi, Mariarosaria Conte, et al.
Nature Chemical Biology|October 26, 2023
Targeting ROS production through inhibition of NADPH oxidasesJoana Reis, Christoph Gorgulla, Marta Massari, et al.
European Journal of Medicinal Chemistry|May 7, 2022
Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular modelsMartina Menna, Francesco Fiorentino, Biagina Marrocco, et al.
Pageof 20